Papers
9
Total Citations
147
H-Index
6
About
Anna Fagotti is a distinguished gynecologic oncologist whose research has significantly advanced minimally invasive surgical techniques for the treatment of gynecological cancers, including ovarian, cervical, and endometrial malignancies. Her work spans a broad spectrum of surgical innovation, from laparoscopic and robotic approaches to cytoreduction and lymphadenectomy, positioning her as a leading voice in the evolution of operative oncology. Among her most influential contributions is her comparative analysis of mini-laparoscopic versus robotic radical hysterectomy in early cervical cancer, which has garnered 36 citations and helped clarify optimal surgical strategies for this patient population. Her pioneering investigations into the Telelap Alf-X robotic platform — including early clinical case series and learning curve assessments — have shaped understanding of how surgeons adopt emerging technologies. With 22 citations, her randomized clinical trial pilot on laparoscopic cytoreduction following neoadjuvant chemotherapy in advanced ovarian cancer reflects her commitment to evidence-based surgical innovation. Fagotti has also addressed surgical equity, examining robotic approaches in obese and frail endometrial cancer patients, and contributed to international consensus guidelines through ESGE/ESGO/SERGS. Her body of work collectively demonstrates a career dedicated to refining safer, less invasive pathways for women facing complex gynecological malignancies.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5
- 6
- 7The new surgical robot Hugo™ RAS for total hysterectomy: a pilot study5 citations · 2023
- 8
- 9